Eligibility was not the failure
HHS’s Office of Inspector General reviewed Phase 3 Provider Relief Fund payments in a statistical sample of 150 providers and a targeted nonstatistical sample of 15. Every sampled provider met federal eligibility requirements.
The payment calculations were a different story. OIG found 65 of 150 statistical-sample payments and 7 of 15 nonstatistical payments were incorrectly calculated or lacked appropriate support. That is 43.33% of the statistical sample and 46.67% of the targeted group.
| Sample | Potential overpayments | Potential underpayments |
|---|---|---|
| Statistical | $655.7M to 39 providers | $131.3M to 26 providers |
| Nonstatistical | $2.3M to 6 providers | $1.1M to 1 provider |
| Combined potential amounts | $658.0M | $132.4M |
The errors cut in both directions
The combined potential overpayment is $658 million, while potential underpayments total $132.4 million. The overpayment figure is nearly five times the underpayment figure, but both show that the control problem was payment accuracy—not a one-direction presumption that every discrepancy benefited providers.
HRSA distributed $19.3 billion to 64,048 providers in Phase 3. OIG’s recommended recovery ceiling equals about 3.41% of that distribution, but the watchdog did not conclude that exactly $658 million is legally collectible. HRSA must review the individual payments and determine actual amounts.
The federal response remains unresolved
OIG recommended that HRSA review the providers with potential overpayments and seek repayment of any amounts confirmed, up to $658 million. HRSA neither concurred nor nonconcurred, but described planned responsive actions.
That posture matters. ‘Potential’ reflects an audit finding requiring agency adjudication, not a final debt. Likewise, underpayments identified in a sample do not automatically establish a legal entitlement to supplemental payment without HRSA review of program terms and documentation.
Method, contribution and limits
What’s the Scoop With Broach combined the statistical and nonstatistical dollar findings, calculated sample error shares and compared the recovery ceiling with total Phase 3 distribution. The original contribution is the two-sided error ledger, preserving the watchdog’s qualifications.
The newsroom did not identify confidential sampled providers or extrapolate a national underpayment total. Statistical projections and targeted-sample results have different meanings; the report keeps them separate except where it transparently adds the published potential amounts.